Orgenesis Statistics
Total Valuation
Orgenesis has a market cap or net worth of $33.05 million. The enterprise value is $60.31 million.
| Market Cap | 33.05M |
| Enterprise Value | 60.31M |
Important Dates
The next estimated earnings date is Friday, August 9, 2024, before market open.
| Earnings Date | Aug 9, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Orgenesis has 47.21 million shares outstanding. The number of shares has increased by 25.30% in one year.
| Shares Outstanding | 47.21M |
| Shares Change (YoY) | +25.30% |
| Shares Change (QoQ) | +10.63% |
| Owned by Insiders (%) | 29.33% |
| Owned by Institutions (%) | 6.43% |
| Float | 29.19M |
Valuation Ratios
The trailing PE ratio is 0.51 and the forward PE ratio is 1.23.
| PE Ratio | 0.51 |
| Forward PE | 1.23 |
| PS Ratio | 62.47 |
| Forward PS | 0.55 |
| PB Ratio | n/a |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 114.02 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.07
| Current Ratio | 0.07 |
| Quick Ratio | 0.03 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -15.96 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -225.30% |
| Return on Capital (ROIC) | -36,435.96% |
| Revenue Per Employee | $3,623 |
| Profits Per Employee | -$312,712 |
| Employee Count | 146 |
| Asset Turnover | 0.03 |
| Inventory Turnover | 169.59 |
Taxes
In the past 12 months, Orgenesis has paid $360,000 in taxes.
| Income Tax | 360,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -41.18% in the last 52 weeks. The beta is 1.23, so Orgenesis's price volatility has been higher than the market average.
| Beta (5Y) | 1.23 |
| 52-Week Price Change | -41.18% |
| 50-Day Moving Average | 0.57 |
| 200-Day Moving Average | 0.57 |
| Relative Strength Index (RSI) | 59.00 |
| Average Volume (20 Days) | 199,930 |
Short Selling Information
The latest short interest is 272,353, so 0.58% of the outstanding shares have been sold short.
| Short Interest | 272,353 |
| Short Previous Month | 194,906 |
| Short % of Shares Out | 0.58% |
| Short % of Float | 0.93% |
| Short Ratio (days to cover) | 1.68 |
Income Statement
In the last 12 months, Orgenesis had revenue of $529,000 and -$45.66 million in losses.
| Revenue | 529,000 |
| Gross Profit | -13.21M |
| Operating Income | -41.54M |
| Pretax Income | -45.30M |
| Net Income | -45.66M |
| EBITDA | -41.26M |
| EBIT | -42.63M |
| Earnings Per Share (EPS) | $1.38 |
Balance Sheet
The company has $565,000 in cash and $27.83 million in debt, giving a net cash position of -$27.27 million or -$0.58 per share.
| Cash & Cash Equivalents | 565,000 |
| Total Debt | 27.83M |
| Net Cash | -27.27M |
| Net Cash Per Share | -$0.58 |
| Equity (Book Value) | -27.72M |
| Book Value Per Share | -0.59 |
| Working Capital | -27.08M |
Cash Flow
In the last 12 months, operating cash flow was -$12.04 million and capital expenditures -$1.02 million, giving a free cash flow of -$13.05 million.
| Operating Cash Flow | -12.04M |
| Capital Expenditures | -1.02M |
| Free Cash Flow | -13.05M |
| FCF Per Share | -$0.39 |
Margins
Gross margin is -2,496.79%, with operating and profit margins of -7,851.98% and -8,630.62%.
| Gross Margin | -2,496.79% |
| Operating Margin | -7,851.98% |
| Pretax Margin | -8,562.57% |
| Profit Margin | -8,630.62% |
| EBITDA Margin | -7,800.19% |
| EBIT Margin | -8,057.84% |
| FCF Margin | -2,467.49% |
Dividends & Yields
Orgenesis does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -25.30% |
| Shareholder Yield | -25.30% |
| Earnings Yield | -138.15% |
| FCF Yield | -39.50% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on November 16, 2017. It was a reverse split with a ratio of 1:12.
| Last Split Date | Nov 16, 2017 |
| Split Type | Reverse |
| Split Ratio | 1:12 |
Scores
Orgenesis has an Altman Z-Score of -13.68 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -13.68 |
| Piotroski F-Score | 1 |